A carregar...
Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use
Background: Monoclonal antibodies are a relatively new therapeutic option for patients with severe refractory asthma, which can be used as an add-on to maintenance therapy, reducing the need for systemic corticosteroid usage, improving asthma symptom control and reducing exacerbations. We report a c...
Na minha lista:
| Publicado no: | F1000Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
F1000 Research Limited
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7443779/ https://ncbi.nlm.nih.gov/pubmed/32864107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.24603.2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|